A new study shows metformin can diminish risk of developing long COVID by more than 40% in overweight and obese patients.
Metformin cuts risk of long COVID by 40% in patients with obesity, trial suggests
Live Science - 14 Jun 2023 21:33
A new study shows metformin can diminish risk of developing long COVID by more than 40% in overweight and obese patients.
Share this Article
Recommended